Cite
HARVARD Citation
Patel, C. et al. (2019). Characterizing the Sources of Pharmacokinetic Variability for TAK‐117 (Serabelisib), an Investigational Phosphoinositide 3‐Kinase Alpha Inhibitor: A Clinical Biopharmaceutics Study to Inform Development Strategy. Clinical pharmacology in drug development. 8 (5), pp. 637-646. [Online].